QuidelOrtho to Participate in Three Upcoming Investor Conferences
QuidelOrtho (Nasdaq: QDEL), a global provider of in vitro diagnostic technologies, has announced its participation in three major investor conferences. The company will engage in fireside chats at the UBS Global Healthcare Conference on November 12, 2024, at 2:00 p.m. ET in Rancho Palos Verdes, the Citi 2024 Global Healthcare Conference on December 4, 2024, at 1:00 p.m. ET in Miami, and the Evercore ISI 7th Annual HealthConX Conference on December 5, 2024, at 10:00 a.m. ET in Coral Gables. Live webcasts and replays will be available through QuidelOrtho's investor relations website.
QuidelOrtho (Nasdaq: QDEL), fornitore globale di tecnologie di diagnostica in vitro, ha annunciato la sua partecipazione a tre importanti conferenze per investitori. L'azienda parteciperà a chiacchierate informali alla UBS Global Healthcare Conference il 12 novembre 2024, alle 14:00 ET a Rancho Palos Verdes, alla Citi 2024 Global Healthcare Conference il 4 dicembre 2024, alle 13:00 ET a Miami, e alla Evercore ISI 7th Annual HealthConX Conference il 5 dicembre 2024, alle 10:00 ET a Coral Gables. Saranno disponibili webcast dal vivo e repliche attraverso il sito web delle relazioni con gli investitori di QuidelOrtho.
QuidelOrtho (Nasdaq: QDEL), proveedor global de tecnologías de diagnóstico in vitro, ha anunciado su participación en tres grandes conferencias para inversionistas. La compañía participará en charlas informales en la UBS Global Healthcare Conference el 12 de noviembre de 2024, a las 2:00 p.m. ET en Rancho Palos Verdes, en la Citi 2024 Global Healthcare Conference el 4 de diciembre de 2024, a la 1:00 p.m. ET en Miami, y en la Evercore ISI 7th Annual HealthConX Conference el 5 de diciembre de 2024, a las 10:00 a.m. ET en Coral Gables. Se ofrecerán transmisiones en vivo y repeticiones a través del sitio web de relaciones con inversionistas de QuidelOrtho.
QuidelOrtho (Nasdaq: QDEL)는 인체 외 진단 기술의 글로벌 제공업체로서, 세 개의 주요 투자자 회의에 참여할 것이라고 발표했습니다. 이 회사는 2024년 11월 12일 오후 2시 ET에 랜초 팔로스 베르데스에서 열리는 UBS 글로벌 헬스케어 컨퍼런스, 2024년 12월 4일 오후 1시 ET에 마이애미에서 열리는 Citi 2024 글로벌 헬스케어 컨퍼런스, 그리고 2024년 12월 5일 오전 10시 ET에 코랄 게이블스에서 열리는 Evercore ISI 제7회 연례 HealthConX 컨퍼런스에서 비공식 대담을 진행할 것입니다. QuidelOrtho의 투자자 관계 웹사이트를 통해 생중계와 다시 보기가 제공될 예정입니다.
QuidelOrtho (Nasdaq: QDEL), un fournisseur mondial de technologies de diagnostic in vitro, a annoncé sa participation à trois grandes conférences pour investisseurs. L'entreprise participera à des discussions informelles lors de la UBS Global Healthcare Conference le 12 novembre 2024 à 14h00 ET à Rancho Palos Verdes, à la Citi 2024 Global Healthcare Conference le 4 décembre 2024 à 13h00 ET à Miami, et à la Evercore ISI 7th Annual HealthConX Conference le 5 décembre 2024 à 10h00 ET à Coral Gables. Des diffusions en direct et des rediffusions seront disponibles sur le site web des relations avec les investisseurs de QuidelOrtho.
QuidelOrtho (Nasdaq: QDEL), ein globaler Anbieter von In-vitro-Diagnosetechnologien, hat seine Teilnahme an drei wichtigen Investorenkonferenzen bekanntgegeben. Das Unternehmen wird an informellen Gesprächen auf der UBS Global Healthcare Conference am 12. November 2024 um 14:00 Uhr ET in Rancho Palos Verdes, auf der Citi 2024 Global Healthcare Conference am 4. Dezember 2024 um 13:00 Uhr ET in Miami und auf der Evercore ISI 7th Annual HealthConX Conference am 5. Dezember 2024 um 10:00 Uhr ET in Coral Gables teilnehmen. Live-Übertragungen und Wiederholungen werden über die Investor-Relations-Website von QuidelOrtho verfügbar sein.
- None.
- None.
UBS Global Healthcare Conference
On Tuesday, November 12, 2024, QuidelOrtho is scheduled to participate in a fireside chat at 2:00 p.m. ET / 11:00 a.m. PT at the conference in
Citi 2024 Global Healthcare Conference
On Wednesday, December 4, 2024, QuidelOrtho is scheduled to participate in a fireside chat at 1:00 p.m. ET / 10:00 a.m. PT at the conference in
Evercore ISI 7th Annual HealthConX Conference
On Thursday, December 5, 2024, QuidelOrtho is scheduled to participate in a fireside chat at 10:00 a.m. ET / 7:00 a.m. PT at the conference in
Interested parties can access the live webcasts and replays of the events in the “Events & Presentations” section of the “Investor Relations” page of QuidelOrtho’s website at https://ir.quidelortho.com/.
QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.
Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic. So that patients, clinicians and health officials can spot trends sooner, respond quicker and chart the course ahead with accuracy and confidence.
Building upon its many years of groundbreaking innovation, QuidelOrtho continues to partner with customers across the healthcare continuum and around the globe to forge a new diagnostic frontier. One where insights and solutions know no bounds, expertise seamlessly connects and a more informed path is illuminated for each of us.
Source: QuidelOrtho Corporation
View source version on businesswire.com: https://www.businesswire.com/news/home/20241028721746/en/
Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
IR@QuidelOrtho.com
Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
media@QuidelOrtho.com
Source: QuidelOrtho Corporation
FAQ
When is QuidelOrtho (QDEL) presenting at the UBS Global Healthcare Conference 2024?
Which investor conferences is QuidelOrtho (QDEL) attending in late 2024?